Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.

about

The making of bispecific antibodies Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies

P2860

Q42323236-3B09F915-31C9-48AD-9F5C-E76D4431EF2A Q42660142-4BEC0E16-869D-43C1-9F21-90D8FA004650 Q58724935-070E10D0-CAC9-4C85-911A-427E4888D69D

P2860

Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.

Item

http://www.wikidata.org/entity/Q38790644

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Design and Validation of a Nov ...... G1-like Bispecific Antibodies.

@en

type

Item

label

Design and Validation of a Nov ...... G1-like Bispecific Antibodies.

@en

prefLabel

Design and Validation of a Nov ...... G1-like Bispecific Antibodies.

@en

P1476

Design and Validation of a Nov ...... gG1-like Bispecific Antibodies

@en

P2093

Annick Ozil

http://www.w3.org/2001/XMLSchema#string

Christian Berthou

http://www.w3.org/2001/XMLSchema#string

Greta Ubiali

http://www.w3.org/2001/XMLSchema#string

Jean Kadouche

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Mach

http://www.w3.org/2001/XMLSchema#string

Justyna Iwaszkiewicz

http://www.w3.org/2001/XMLSchema#string

Martine Duonor-Cérutti

http://www.w3.org/2001/XMLSchema#string

Olivier Michielin

http://www.w3.org/2001/XMLSchema#string

Pierre Cérutti

http://www.w3.org/2001/XMLSchema#string

Sylvie Choblet

http://www.w3.org/2001/XMLSchema#string

P2860

Affinity and avidity in antibody-based tumor targeting

CHARMM: the biomolecular simulation program

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair

All-atom empirical potential for molecular modeling and dynamics studies of proteins

Alternative molecular formats and therapeutic applications for bispecific antibodies

Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties

Macromolecular modeling with rosetta

Automatic protein design with all atom force-fields by exact and heuristic optimization.

Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.

P304

3199-3211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1501592

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

Josée Golay

Martine Pugniere

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26921308

http://www.w3.org/2001/XMLSchema#string

Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.

about

P2860

P2860

Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698